1. Home
  2. ARWR vs FBK Comparison

ARWR vs FBK Comparison

Compare ARWR & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • FBK
  • Stock Information
  • Founded
  • ARWR 2003
  • FBK 1906
  • Country
  • ARWR United States
  • FBK United States
  • Employees
  • ARWR N/A
  • FBK N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • FBK Major Banks
  • Sector
  • ARWR Health Care
  • FBK Finance
  • Exchange
  • ARWR Nasdaq
  • FBK Nasdaq
  • Market Cap
  • ARWR 1.7B
  • FBK 2.0B
  • IPO Year
  • ARWR 1993
  • FBK 2016
  • Fundamental
  • Price
  • ARWR $11.24
  • FBK $40.61
  • Analyst Decision
  • ARWR Buy
  • FBK Hold
  • Analyst Count
  • ARWR 11
  • FBK 5
  • Target Price
  • ARWR $41.44
  • FBK $54.00
  • AVG Volume (30 Days)
  • ARWR 2.3M
  • FBK 321.8K
  • Earning Date
  • ARWR 05-08-2025
  • FBK 04-14-2025
  • Dividend Yield
  • ARWR N/A
  • FBK 1.87%
  • EPS Growth
  • ARWR N/A
  • FBK 14.69
  • EPS
  • ARWR N/A
  • FBK 2.73
  • Revenue
  • ARWR $2,500,000.00
  • FBK $465,280,000.00
  • Revenue This Year
  • ARWR $4,380.43
  • FBK $37.87
  • Revenue Next Year
  • ARWR $64.24
  • FBK $19.11
  • P/E Ratio
  • ARWR N/A
  • FBK $14.88
  • Revenue Growth
  • ARWR N/A
  • FBK 2.18
  • 52 Week Low
  • ARWR $9.57
  • FBK $33.35
  • 52 Week High
  • ARWR $30.41
  • FBK $58.88
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 38.40
  • FBK 35.58
  • Support Level
  • ARWR $9.64
  • FBK $39.47
  • Resistance Level
  • ARWR $12.93
  • FBK $43.90
  • Average True Range (ATR)
  • ARWR 1.18
  • FBK 2.11
  • MACD
  • ARWR 0.18
  • FBK -0.15
  • Stochastic Oscillator
  • ARWR 43.21
  • FBK 21.84

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About FBK FB Financial Corporation

FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.

Share on Social Networks: